MEXICO CITY (Reuters) – Mexico Foreign Minister Marcel Ebrard said on Monday the country will host phase three trials of the COVID-19 vaccine by France’s Sanofi.
Mexico’s health regulator Cofepris gave approval for trials of the vaccine, which uses a recombinant protein-based technology, Ebrard added.
(Reporting by Raul Cortes, writing by Cassandra Garrison)